Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Cannot redeclare control with same name "grid_6_title_typography_text_decoration"
The majority of people who start them dont stop taking them
GLP-1 receptor agonists (GLP-1 RAs) are newer medications that were initially released as treatment for diabetes In higher doses, they have shown promising results in weight loss also Wegovy (semaglutide) was the first GLP-1 RA approved for weight loss by the FDA Zepbound (tirzepatide) was just recently approved by the FDA Early data shows better weight loss with Zepbound/tirzepatide than Wegovy/semaglutide What are GLP-1 receptor agonists and why do they work
Other possible side effects include indigestion, bloating, burping, gas, reflux or heartburn, tiredness, dizziness, low blood pressure, reduced appetite, hair loss, fast pulse and injection site reactions such as redness or itching
It improves insulin sensitivity and ramps up fat oxidation
The main barriers are access and cost
